BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24124538)

  • 1. Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity.
    Chougule A; Prabhash K; Noronha V; Joshi A; Thavamani A; Chandrani P; Upadhyay P; Utture S; Desai S; Jambhekar N; Dutt A
    PLoS One; 2013; 8(10):e76164. PubMed ID: 24124538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor mutation subtypes and geographical distribution among Indian non-small cell lung cancer patients.
    Choughule A; Noronha V; Joshi A; Desai S; Jambhekar N; Utture S; Thavamanni A; Prabhash K; Dutt A
    Indian J Cancer; 2013; 50(2):107-11. PubMed ID: 23979200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer.
    Cote ML; Haddad R; Edwards DJ; Atikukke G; Gadgeel S; Soubani AO; Lonardo F; Bepler G; Schwartz AG; Ethier SP
    J Thorac Oncol; 2011 Mar; 6(3):627-30. PubMed ID: 21317742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor mutations in non- small cell lung cancers in a multiethnic malaysian patient population.
    Liam CK; Leow HR; How SH; Pang YK; Chua KT; Lim BK; Lai NL; Kuan YC; Pailoor J; Rajadurai P
    Asian Pac J Cancer Prev; 2014; 15(1):321-6. PubMed ID: 24528049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor mutation status in pulmonary adenocarcinoma: Multi-institutional data discussion at national conference of "Lung Cancer Management in Indian context".
    Nakra T; Mehta A; Bal A; Nambirajan A; Mishra D; Midha D; Gupta N; Arora N; Gupta P; Gupta P; Singh V; Jain D
    Curr Probl Cancer; 2020 Jun; 44(3):100561. PubMed ID: 32169258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP).
    Arrieta O; Cardona AF; Martín C; Más-López L; Corrales-Rodríguez L; Bramuglia G; Castillo-Fernandez O; Meyerson M; Amieva-Rivera E; Campos-Parra AD; Carranza H; Gómez de la Torre JC; Powazniak Y; Aldaco-Sarvide F; Vargas C; Trigo M; Magallanes-Maciel M; Otero J; Sánchez-Reyes R; Cuello M
    J Thorac Oncol; 2015 May; 10(5):838-843. PubMed ID: 25634006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER).
    Shi Y; Au JS; Thongprasert S; Srinivasan S; Tsai CM; Khoa MT; Heeroma K; Itoh Y; Cornelio G; Yang PC
    J Thorac Oncol; 2014 Feb; 9(2):154-62. PubMed ID: 24419411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of epidermal growth factor receptor mutations in Jordanian lung adenocarcinoma patients at diagnosis.
    Obeidat N; Awidi A; Ababneh N; Shomaf M; Al-Adaily T; Jaber M; Al-Khateeb M; Abbasi S
    J Cancer Res Ther; 2016; 12(2):616-9. PubMed ID: 27461620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians.
    Zhou W; Christiani DC
    Chin J Cancer; 2011 May; 30(5):287-92. PubMed ID: 21527061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer.
    Tsao AS; Tang XM; Sabloff B; Xiao L; Shigematsu H; Roth J; Spitz M; Hong WK; Gazdar A; Wistuba I
    J Thorac Oncol; 2006 Mar; 1(3):231-9. PubMed ID: 17409862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethnic differences and functional analysis of MET mutations in lung cancer.
    Krishnaswamy S; Kanteti R; Duke-Cohan JS; Loganathan S; Liu W; Ma PC; Sattler M; Singleton PA; Ramnath N; Innocenti F; Nicolae DL; Ouyang Z; Liang J; Minna J; Kozloff MF; Ferguson MK; Natarajan V; Wang YC; Garcia JG; Vokes EE; Salgia R
    Clin Cancer Res; 2009 Sep; 15(18):5714-23. PubMed ID: 19723643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer.
    Batra U; Biswas B; Prabhash K; Krishna MV
    BMJ Open Respir Res; 2023 Jun; 10(1):. PubMed ID: 37321664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based incidence rates and increased risk of EGFR mutated non-small cell lung cancer in Māori and Pacifica in New Zealand.
    Aye PS; McKeage MJ; Tin Tin S; Khwaounjoo P; Elwood JM
    PLoS One; 2021; 16(5):e0251357. PubMed ID: 33961689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma.
    Smits AJ; Kummer JA; Hinrichs JW; Herder GJ; Scheidel-Jacobse KC; Jiwa NM; Ruijter TE; Nooijen PT; Looijen-Salamon MG; Ligtenberg MJ; Thunnissen FB; Heideman DA; de Weger RA; Vink A
    Cell Oncol (Dordr); 2012 Jun; 35(3):189-96. PubMed ID: 22528563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR mutations in US Hispanic versus non-Hispanic white patients with lung adenocarcinoma.
    Zhang W; McQuitty EB; Olsen R; Fan H; Hendrickson H; Tio FO; Newton K; Cagle PT; Jagirdar J
    Arch Pathol Lab Med; 2014 Apr; 138(4):543-5. PubMed ID: 23937608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of cigarette smoking on the frequency of and qualitative differences in KRAS mutations in Korean patients with lung adenocarcinoma.
    Kim HR; Ahn JR; Lee JG; Bang DH; Ha SJ; Hong YK; Kim SM; Nam KC; Rha SY; Soo RA; Riely GJ; Kim JH; Cho BC
    Yonsei Med J; 2013 Jul; 54(4):865-74. PubMed ID: 23709419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking status and self-reported race affect the frequency of clinically relevant oncogenic alterations in non-small-cell lung cancers at a United States-based academic medical practice.
    Yamaguchi N; Vanderlaan PA; Folch E; Boucher DH; Canepa HM; Kent MS; Gangadharan SP; Majid A; Kocher ON; Goldstein MA; Huberman MS; Costa DB
    Lung Cancer; 2013 Oct; 82(1):31-7. PubMed ID: 23932486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of EGFR mutations in lung adenocarcinoma patients - A study from tertiary cancer center of South India.
    Nayanar SK; Mohan A; Shenoy P; Saravanan M; Gopinath V; Deepak Roshan VG
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S712-S718. PubMed ID: 38384044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent epidermal growth factor receptor mutation patterns between smokers and non-smokers with lung adenocarcinoma.
    Tseng JS; Wang CL; Yang TY; Chen CY; Yang CT; Chen KC; Hsu KH; Tsai CR; Chang GC
    Lung Cancer; 2015 Dec; 90(3):472-6. PubMed ID: 26474957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of epidermal growth factor receptor mutations in lung cancers in Indian population.
    Mehta J
    Indian J Cancer; 2013; 50(2):102-6. PubMed ID: 23979199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.